Generic User Fee Agreement Includes FDA Pledge To Determine Best Use Of Foreign Regulator Inspections
This article was originally published in The Pink Sheet Daily
Executive Summary
Draft commitment letter could be first step down globalization road in which FDA relies more on foreign governments to boost manufacturing oversight.